id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-312350-klxw65qa	Khan, Zafran	Diagnostic approaches and potential therapeutic options for coronavirus disease (COVID-19)	2020-09-30		.txt	text/plain	1017	84	47	To date, more than 300 clinical trials have been conducted on various antiviral drugs, and immunomodulators are being evaluated at various stages of COVID-19. This review is aimed to collect and summarize a list of drugs used to treat COVID-19 for instance, dexamethasone, chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, remdesivir, tociluzimab, nitazoxanide, and ivermectin. WHO 154 launches the "Solidarity" clinical trial for COVID-19 treatment to further evaluate remdesivir, 155 hydroxychloroquine/chloroquine, and lopinavir-ritonavir with and without interferon-beta [64] . Recently in Singapore, the five COVID-19 patients were subjected to treatment with lopinavir 258 and ritonavir within 1 to 3 days of desaturation, but evidence of clinical use is ambiguous. Clinical and 708 microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-709 19 patients with at least a six-day follow up: A pilot observational study. Effective treatment of severe COVID-749 19 patients with tocilizumab Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-779 analysis	./cache/cord-312350-klxw65qa.txt	./txt/cord-312350-klxw65qa.txt